Ovesco Messestand
Conference Report of the United European Gastroenterology Week (UEGW) 2019: OTSC® shows superiority over conventional
A randomized controlled trial presented at the American College of Gastroenterology (ACG) meeting shows the
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
Ovesco Endoscopy is pleased to announce that the stentfix OTSC® System Set has received market
93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with
Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %
96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower
Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success
OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical success rate of